← Lookup

UnitedHealthcare (Commercial) · sacroiliac joint fusion

v1verified 2026-07-24needs re-verificationmanual-pull source

✓ conditional · commercial

Delegated gates: diagnostic block %, provocative-test count, conservative duration -> InterQual CP: SI Joint Injection + InterQual Client-Defined CP: SI Joint Fusion (Custom, UHG) — gated. The cell does not state numbers for delegated gates — confirm the operative criteria with UM/billing.

Criteria checklist

0 of 8 ticked
Indications
  • enumerated: yes
  • covered:
      • name: Minimally invasive SI joint fusion with a Titanium Triangular Implant system (per InterQual)
      • name: Open SI joint fusion (per InterQual)
      • name: SI joint injections in certain circumstances (per InterQual)
  • investigational:
    • SI joint fusion with any other device, or for any other indication
    • sacral lateral branch nerve blocks as a diagnostic-before-RFA step
Documented pathology (objective basis)required
Conservative care
  • required: not stated in the policy
  • min duration months: not stated in the policy
  • note: delegated to InterQual (gated)
Trial
  • required: no
  • min duration days: not stated in the policy
  • success criteria: not stated in the policy
  • threshold is binding: no
Psychological evaluation
  • required: no
  • must clear: no
  • note posture: not addressed in public policy
Diagnostic block (SI joint)
  • required before: MIS SI fusion
  • relief threshold pct: not stated in the policy
  • note: thresholds reside in InterQual; not in the public UHC policy
Provocative tests
  • required: not stated in the policy
  • note: delegated to InterQual (typical pattern ~3-of-5, not disclosed publicly)
Quantity limits
  • applies: yes
  • note: SI injections also subject to site-of-service review (separate policy)
Payor-specific notes

UHC's public SI policy ENUMERATES the proven categories — MIS fusion with a Titanium Triangular Implant system, and open fusion (both "per InterQual"), and SI injections in certain circumstances — but DELEGATES all quantitative gates (diagnostic-block %, provocative-test count, conservative-care duration) to InterQual (including a UHG Client-Defined custom criteria set), which is licensed/gated and NOT in the public PDF. Those fields are null with a delegation note; pull the InterQual criteria to complete (needs_reverification). SI fusion with any other device/indication, and sacral lateral branch blocks as a diagnostic-before-RFA step, are unproven. From the actual fetched UHC PDF. (CPT note: 27279 = MIS transfixing device; 27278 intra-articular no-cortical-piercing; 27280 open.)

Ticks are a documentation aid — nothing is stored; they reset on reload.

Dot phrase

Self-contained narrative A&P attestation. `***` = fill-in. Maps to UHC 2026T0621N (Sacroiliac Joint Interventions). UHC's public policy enumerates covered CATEGORIES only; the quantitative gates live in licensed InterQual (incl. a UHG Client-Defined custom set) and are NOT public.

.SIFUSIONUHC
.SIFUSIONUHC

Assessment: *** — sacroiliac joint pain on the *** side, supported by examination and
imaging: *** . UHC's public policy does not enumerate diagnostic criteria; they reside in
InterQual.

Medical necessity per UHC 2026T0621N, whose quantitative gates sit in gated InterQual: the
covered category here is minimally invasive SI joint fusion with a Titanium Triangular
Implant system (open SI joint fusion is a separate covered category, also per InterQual);
fusion with any other device, or for any other indication, is unproven and not covered.
Diagnostic SI joint block(s) were performed *** , with the actual dates and percentage relief
documented — UHC publishes no relief threshold. Provocative testing: *** , with each maneuver
and result documented — UHC publishes no required count. Conservative care: *** , with
modalities and dates documented — the public policy states no required duration. No sacral
lateral branch nerve block (64451) is billed or planned as a diagnostic step before RFA.

Plan: MIS sacroiliac joint fusion with a Titanium Triangular Implant system on the *** side,
CPT 27279. Risks, benefits, and alternatives discussed; consent obtained.

Where this payor diverges from the Medicare baseline

  • device line (Titanium Triangular Implant system only; open fusion separate category)
  • gates line (block %, provocative-test count, conservative duration delegated to gated InterQual)
  • exclusion (sacral lateral branch blocks as diagnostic-before-RFA)

Cautions

  • [!] Quantitative gates delegated to gated InterQual (incl. SI Joint Fusion Custom UHG criteria) — CONFIRM the actual thresholds with UM/billing. The InterQual-typical patterns (UNVERIFIED) are TWO image-guided intra-articular blocks EACH >=75%, and ~3 of 5 provocative tests positive; do not chart them as though UHC published them. Coding: 27279 = MIS transfixing device; 27278 = intra-articular without cortical piercing; 27280 = open arthrodesis. Sacral lateral branch blocks (64451) before RFA are not covered. Prior auth not stated in-policy — governed by a separate UHC PA list. SI injections are also subject to site-of-service review (separate policy). Regenerate if `uhc-commercial-si-fusion.md` `version` advances past `source_version`.

Prior-auth pathway

  • required: not stated in the policy
  • note: not stated in-policy; governed by a separate UHC PA list

Provenance

Report an issue with this cell

Change history

  • 2026-07-24commercial cells: re-verify 27 source PDFs by SHA-256 (Carelon/eviCore/UHC/Cigna) - all unchanged vs committed archive; last_verified -> 2026-07-24 3615c231f0
  • 2026-06-30Archive commercial source PDFs into sources/ + wire source_file/source_hash c5466694c8
  • 2026-06-28Add commercial SI Joint Fusion cells: Anthem, UHC, Cigna 0b3dab6dcb